2010 Annual Meeting | Neuro-oncology Update II: Systemic Cancer

Date Friday 04/16/10

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Lisa M. DeAngelis, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the differential diagnoses and treatment of brain metastases, leptomeningeal metastases, and vascular, metabolic, and paraneoplastic complications of cancer.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Didactic

Event Timeline
09:00 AM - 09:40 AM		Brain Metastases David Schiff, MD, FAAN
09:40 AM - 09:50 AM		Questions and Answers David Schiff, MD, FAAN
09:50 AM - 10:30 AM		Leptomeningeal Metastases Jennifer L. Clarke, MD, MPH
10:30 AM - 10:40 AM		Questions and Answers Jennifer L. Clarke, MD, MPH
10:40 AM - 11:00 AM		Break
11:00 AM - 11:40 AM		Paraneoplastic Syndromes Josep O. Dalmau, MD, PhD, FAAN
11:40 AM - 11:50 AM		Questions and Answers Josep O. Dalmau, MD, PhD, FAAN
11:50 AM - 12:30 PM		Vascular Disease in Cancer Patients Lisa M. DeAngelis, MD, FAAN
12:30 PM - 12:40 PM		Questions and Answers Lisa M. DeAngelis, MD, FAAN
12:40 PM - 12:45 PM		Discussion

Faculty Disclosures
Lisa M. DeAngelis, MD, FAAN	Dr. DeAngelis has nothing to disclose.
Jennifer L. Clarke, MD, MPH	The institution of Dr. Clarke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. The institution of Dr. Clarke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. The institution of Dr. Clarke has received research support from Agios. The institution of Dr. Clarke has received research support from Servier. The institution of Dr. Clarke has received research support from Merck.
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
David Schiff, MD, FAAN	Dr. Schiff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Pharmaceutical. Dr. Schiff has received publishing royalties from a publication relating to health care.